This prospective, double-masked study randomized 286 dry eye patients to receive a single drop of 1% or 3% diquafosol or placebo ophthalmic solutions, six times a day for six weeks. Diquafosol, a P2Y2 receptor agonist, promotes secretion of aqueous tears and mucins on the ocular surface. At four weeks, fluorescein corneal staining scores, rose bengal corneal and conjunctival staining scores, and dry eye syndrome scores improved significantly with both dosages of diquafosol compared to placebo.
News from the FSO
The Centers for Disease Control and Prevention and the U.S. Food and Drug Administration are advising physicians to halt use of any product originating from the New England Compounding Center in Framingham, Mass. For ophthalmology practices, this would include Avastin, which NECC compounds for use in intravitreal injections. |
From the American Academy of Ophthalmology
From the American Academy of Ophthalmology
From the American Academy of Ophthalmology
From the American Academy of Ophthalmology
This meta-analysis has found a pooled 2 percent reduced odds of myopia per additional hour spent outdoors per week in children and adolescents up to 20 years old. This is equivalent to an odds ratio of 0.87 for each hour outdoors per day. These results, considered in conjunction with a systematic review of studies not meeting the meta-analysis criteria, suggest that increasing time spent outdoors could confer a modest, but significant, reduced risk of developing myopia and its progression. Ophthalmology, October 2012
FOR IMMEDIATE RELEASE Contact: DOH Communications
From the American Academy of Ophthalmology
From the American Academy of Ophthalmology